Effects of Combined Pentadecanoic Acid and Tamoxifen Treatment on Tamoxifen Resistance in MCF−7/SC Breast Cancer Cells

Estrogen receptors are indicators of breast cancer adaptability to endocrine therapies, such as tamoxifen. Deficiency or absence of estrogen receptor α (ER−α) in breast cancer cells results in reduced efficacy of endocrine therapy. Here, we investigated the effect of combined tamoxifen and pentadeca...

Descripción completa

Detalles Bibliográficos
Autores principales: To, Ngoc Bao, Truong, Vi Nguyen-Phuong, Ediriweera, Meran Keshawa, Cho, Somi Kim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9570034/
https://www.ncbi.nlm.nih.gov/pubmed/36232636
http://dx.doi.org/10.3390/ijms231911340

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9570034/
https://www.ncbi.nlm.nih.gov/pubmed/36232636
http://dx.doi.org/10.3390/ijms231911340

Ejemplares similares